IBTICARE

ibticare-logo

IbtiCare has invented an innovative antibacterial technology based on Physical Vapor Deposition (PVD). This cutting edge technology can coat many surfaces with advanced nanoparticles and make them antibacterial against all types of dangerous bacteria that are resistant to any drugs. From many aspects, technology is superior compared to the current antibacterial methods. Their antibacterial technology has passed clinical trials and has been validated by operating leaders in healthcare.

#Financial #Website #More

IBTICARE

Social Links:

Industry:
Health Care Hospital Nanotechnology

Founded:
2016-01-01

Address:
Lausanne, Vaud, Switzerland

Country:
Switzerland

Website Url:
http://www.ibticare.ch

Total Employee:
1+

Status:
Closed

Contact:
+41 78 966 44 34

Email Addresses:
[email protected]

Total Funding:
30.8 K USD


Investors List

venturekick_image

Venture Kick

Venture Kick investment in Grant - IbtiCare

masschallenge_image

MassChallenge

MassChallenge investment in Non Equity Assistance - IbtiCare

venturekick_image

Venture Kick

Venture Kick investment in Grant - IbtiCare

Official Site Inspections

http://www.ibticare.ch

Unable to get host informations!!!

Loading ...

More informations about "IbtiCare"

IbtiCare - Crunchbase Company Profile & Funding

IbtiCare has invented an innovative antibacterial technology based on Physical Vapor Deposition (PVD). This cutting edge technology can coat many surfaces with advanced nanoparticles and โ€ฆSee details»

IbtiCare - Venture Kick

IbtiCare: IbtiCare is a spin-off from EPFL, which explores innovative and sustainable antibacterial solutions for different healthcare products in order to solve some of the worldโ€™s biggest โ€ฆSee details»

IbtiCare Company Profile 2024: Valuation, Funding & Investors

IbtiCare General Information Description. Developer of antibacterial technology intended to eradicate bacterial infection in the world. The company's solutions are fast reactive, extremely โ€ฆSee details»

IbtiCare - Venture Kick

IbtiCare is a spin-off from EPFL, which explores innovative and sustainable antibacterial solutions for different healthcare products in order to solve some of the worldโ€™s biggest challenges in โ€ฆSee details»

IbtiCare - Products, Competitors, Financials, Employees, โ€ฆ

About IbtiCare. IbtiCare is developing a product for antibacterial wound dressing. It deposits new antibacterial particles on surfaces and makes them self-cleaning. IbtiCare aims to find โ€ฆSee details»

RetinAI Medical and IbtiCare win the second stage of Venture Kick

Jul 14, 2017 RetinAI Medical and IbtiCare win the second stage of Venture Kick. 14.07.2017. The two startup projects and their teams win CHF 20โ€™000 each. They are now getting ready for โ€ฆSee details»

IbtiCare - Funding, Financials, Valuation & Investors - Crunchbase

IbtiCare is an R&D health care firm that makes technology for medical textile and devices permanently anti-bacterial. Search Crunchbase. Start Free Trial . ... How much funding has โ€ฆSee details»

IbtiCare - F6S

IbtiCare founders & employees. Alba Camarasa. Lausanne, Switzerland. Not required. Laboratory Engineer R&D flow chemistry · Employee @ICIQ Ertflow. Engineer @IbtiCare. Sami Rtimi โ€ฆSee details»

IbtiCare - Crunchbase

IbtiCare is an R&D health care firm that makes technology for medical textile and devices permanently anti-bacterial. Search Crunchbase. Start Free Trial . Chrome Extension. โ€ฆSee details»

IbtiCare | VentureRadar

IbtiCare has invented an innovative antibacterial technology based on Physical Vapor Deposition (PVD). This cutting edge technology can coat many surfaces with advanced nanoparticles and โ€ฆSee details»

IbtiCare - Company Profile & Staff Directory - ContactOut

IbtiCare is a spin-off from EPFL. IbtiCare is a research and development company, which explores innovative and sustainable antibacterial solutions for different healthcare products in โ€ฆSee details»

Accelerating Innovation in the Fight Against Antimicrobial โ€ฆ

Jun 1, 2024 At LionsHub Capital, we are committed to identifying and nurturing groundbreaking technologies that have the potential to create a profound impact on both environment and โ€ฆSee details»

RetinAI Medical and IbtiCare win the second stage of Venture Kick

IbtiCareโ€™s antibacterial coating can be applied on many surfaces e.g. medical textile or complex shape medical devices. The deposited materials are strongly adhesive to the substrate and โ€ฆSee details»

Helen Smith โ€“ Digital Media (intern) โ€“ IBTICARE | LinkedIn

IBTICARE is a highly innovative startup from EPFL which explore a unique antibacterial technology, addressing different healthcare applications in order to eradicate one of the most โ€ฆSee details»

Ibticare Group | Lausanne - Facebook

Ibticare Group, Lausanne, Switzerland. 24 likes. We make surfaces self-Sterilising by deposition of an effective, adhesive and uniform antibacterialSee details»

Dr. Sami Rtimi | CSO | Ibticare Group

Explore the groundbreaking work of Dr. Sami Rtimi, our worldwide leading member in nanotechnology, focusing on self-sterilizing surfaces for clinical use. With over 15 years of โ€ฆSee details»

RetinAI Medical and IbtiCare win the second stage of Venture Kick

RetinAI Medical and IbtiCare win the second stage of Venture Kick. 14.07.2017. The two startup projects and their teams win CHF 20โ€™000 each. They are now getting ready for the programโ€™s โ€ฆSee details»

Team Archives - Ibticare Group

IbtiCare Group develops innovative and sustainable antibacterial solutions for healthcare and non-healthcare industries to safeguard humanity against AMR/MDR threats. Get in touch โ€ฆSee details»

Four innovative startup projects win the first stage of Venture Kick

Four novel startup projects won the first stage of Venture Kick recently. They will receive CHF 10'000 each, as well as hands-on execution support at the kickers camps, before competing โ€ฆSee details»

RetinAI collaborates with Novartis to bring artificial intelligence ...

Dec 8, 2020 RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAIโ€™s IT solutions and artificial intelligence tools shall be employed to support โ€ฆSee details»

linkstock.net © 2022. All rights reserved